VivaVision Biotech (VivaVision), a clinical-stage, privately held biotechnology company focused on developing innovative treatments for ocular diseases, today announced positive topline results from ...

Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...

“I used to model for ASOS but when I fell pregnant with ... Mum of three Angela Armin, 54, suffers from uveitis, a rare condition that has resulted in partial blindness in both eyes.

The model used to summarize this release may make ... Graves’ Disease and Thyroid Eye Disease, while developing the IMVT-1402 program to a total of six indications, now including Sjögren ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Children with early-onset atopic dermatitis (AD) have an elevated risk for pediatric uveitis, according to a study published ...

particularly in the diagnosis and treatment of uveitis, where the symposium is poised to mark a tangible shift in the future of eye care in Qatar.

Only half of patients showed clinical improvement attributed to the medication, but only one new complication occurred.

Non-infectious uveitis is a group of serious conditions characterized by intraocular inflammation that, if inadequately ...

A retrospective cohort analysis shows that pediatric patients with noninfectious uveitis face lower recurrence rates when ...